| Shalva Lehrfield, MA, CCC-SLP | |
|
6333 N Whipple St Apt 2, Chicago, IL 60659-1450 | |
| (773) 860-1784 | |
| Not Available |
| Full Name | Shalva Lehrfield |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 6333 N Whipple St Apt 2, Chicago, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003545559 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.015543 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shalva Lehrfield, MA, CCC-SLP 6333 N Whipple St Apt 2, Chicago, IL 60659-1450 Ph: (773) 860-1784 | Shalva Lehrfield, MA, CCC-SLP 6333 N Whipple St Apt 2, Chicago, IL 60659-1450 Ph: (773) 860-1784 |
News Archive
Companies seeking to commercialize seafood products made from the cells of fish or shellfish should use the term "cell-based" on product labels, according to a Rutgers study - the first of its kind - in the Journal of Food Science.
A comprehensive study of the components of the delivery of modern-day cancer care in community oncology practices revealed that Medicare covers only 56% of the actual costs of administering chemotherapy and providing related infusion room services to seniors with cancer. The remaining costs - for essential services provided such as treatment planning, care coordination, and follow-up care planning - are not reimbursed by Medicare, causing many oncology practices to struggle to continue to provide care under the Medicare program.
Dr. James Atkins, founder of the Texas Sinus Center (www.texassinuscenter.com), today announced he is now offering the FinESS® Sinus Treatment, a minimally invasive treatment that breaks the cycle of chronic sinusitis (CRS) at Foundation Surgical Hospital of San Antonio.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 7 days ago
Mary Fleming, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3722 N Paris Ave, Chicago, IL 60634 Phone: 773-625-6760 | |
Ms. Gwendolyn Sue Julian, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1652 N Lockwood Ave, Chicago, IL 60639 Phone: 773-836-2393 Fax: 773-836-0110 | |
Mrs. Nikki Miner, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1206 W Henderson St # 2s, Chicago, IL 60657 Phone: 847-708-1116 | |
Premier Speech Therapy, Ltd Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3711 N Richmond St, Chicago, IL 60618 Phone: 312-339-7673 Fax: 484-210-2342 | |
Aw Therapy Services, Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4717 W Patterson Ave, Chicago, IL 60641 Phone: 773-330-6220 Fax: 773-439-2374 | |
Mrs. Adrienne Loury, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7505 S Aberdeen St, Chicago, IL 60620 Phone: 773-308-4242 Fax: 773-488-3903 | |
Elissa Margaret Larkin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 345 E Superior St, Chicago, IL 60611 Phone: 312-238-1000 |